Nicole M Agostino

Summary

Publications

  1. ncbi Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
    Nicole M Agostino
    Division of Hematology Oncology, Department of Medicine, Penn State Milton S Hershey Medical Center, Hershey, PA 17033 0850, USA
    J Oncol Pharm Pract 17:197-202. 2011
  2. ncbi Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer
    Monika Joshi
    Division of Hematology Oncology, Penn State Hershey Cancer Institute, Penn State Milton S Hershey Medical Center, Hershey, PA 17033 0850, USA
    South Med J 104:736-40. 2011

Collaborators

Detail Information

Publications2

  1. ncbi Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
    Nicole M Agostino
    Division of Hematology Oncology, Department of Medicine, Penn State Milton S Hershey Medical Center, Hershey, PA 17033 0850, USA
    J Oncol Pharm Pract 17:197-202. 2011
    ..These results also suggest that inhibition of a tyrosine kinase, be it c-kit, PDGFRβ or some other undefined target, may improve diabetes mellitus BG control and it deserves further study as a potential novel therapeutic option...
  2. ncbi Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer
    Monika Joshi
    Division of Hematology Oncology, Penn State Hershey Cancer Institute, Penn State Milton S Hershey Medical Center, Hershey, PA 17033 0850, USA
    South Med J 104:736-40. 2011
    ..Soy products are able to affect PSA kinetics in some men with prostate cancer, and this effect has been attributed to the decreased expression of the androgen receptor and other mechanisms...